Skip to main content

Search Results

Your search for "" returned 8200 results.

Beckerle Elected to National Academy of Sciences

Beckerle Elected to National Academy of Sciences

Huntsman Cancer Institute at the University of Utah The National Academy of Sciences has elected Mary Beckerle, PhD, Huntsman Cancer Institute CEO and distinguished professor of biology and oncological sciences at the University of Utah, as a member. Dr. Beckerle is among 120 newly elected members of the academy. Read More
Sameer Patel Co Authors New Textbook on Cosmetic Breast Surgery

Sameer Patel Co-Authors New Textbook on Cosmetic Breast Surgery

Fox Chase Cancer Center, Temple Health Sameer Patel, MD, FACS, chief of the Division of Plastic and Reconstructive Surgery in the Department of Surgical Oncology at Fox Chase Cancer Center and the Temple University Health System, has co-authored a new textbook, Cosmetic Breast Surgery. Read More

Arizona Clinical Trials Network Launched

The University of Arizona Cancer Center Arizona residents, including underserved and underrepresented populations, will have better access to cutting-edge cancer therapies as the University of Arizona Cancer Center offers its clinical trials at locations across the state. The network is a collaboration among communities, hospitals, and physicians that will enable the university’s clinical research to reach more patients. Read More

Study: Jump in Cancer Diagnoses at 65 Implies Patients Wait for Medicare

Stanford Cancer Institute A new study has found a substantial rise nationwide in new diagnoses at age 65 for lung, breast, colon, and prostate cancer, suggesting that many wait for Medicare to kick in before they seek care. Read More
Study Analyzes Clinical Economic Impact of Hemorrhagic Cystitis in Stem Cell Transplant Patients

Study Analyzes Clinical, Economic Impact of Hemorrhagic Cystitis in Stem Cell Transplant Patients

The University of Kansas Cancer Center A study led by The University of Kansas Cancer Center, with AlloVir, Certara, and Memorial Sloan Kettering Cancer Center, compares the economic burden, health resource utilization, and clinical outcomes among allogeneic hematopoietic stem cell transplant recipients with virus-associated hemorrhagic cystitis to those without virus-associated hemorrhagic cystitis. Joseph McGuirk, DO, is lead author. Read More
Juckett Named CTO CGI Medical Director

Juckett Named CTO-CGI Medical Director

Masonic Cancer Center, University of Minnesota Mark Juckett, MD, was appointed medical director of the Masonic Cancer Center Clinical Trials Office for the Cellular, Gene and Immunotherapy Initiative (CTO-CGI), succeeding Shernan Holtan, MD, who initiated the role. Dr. Juckett was recruited from the University of Wisconsin - Madison. Read More
Maquat Awarded 2021 Wolf Prize in Medicine

Maquat Awarded 2021 Wolf Prize in Medicine

Wilmot Cancer Institute, UR Medicine Lynne E. Maquat, PhD, the founding director of the Center for RNA Biology at the University of Rochester, has been honored with the 2021 Wolf Prize in Medicine. She shares the award with Joan Steitz, PhD, at Yale School of Medicine, and Adrian Krainer, PhD, at Cold Spring Harbor Laboratory. Read More
6 Million Awarded to Decrease Disparities in Cancer Clinical Trials

$6 Million Awarded to Decrease Disparities in Cancer Clinical Trials

The Tisch Cancer Institute at Mount Sinai Mount Sinai researchers have received a grant award to lead a collaborative team of New York institutions in an initiative that addresses disparities in the participation of Black, indigenous, and people of color in cancer clinical trials. Stand Up To Cancer® awarded $6 million to a multi-institutional team that will be led by Nina Bickell, MD, MPH. Read More
10 Million Gift to Support Research Initiatives New Director

$10 Million Gift to Support Research Initiatives, New Director

The University of Chicago Medicine Comprehensive Cancer Center A $10 million grant from the AbbVie Foundation will support scientific and educational activities at the University of Chicago Medicine Comprehensive Cancer Center under the leadership of newly appointed director, Kunle Odunsi, MD, PhD. Read More

Having a Single Personal Doctor May Sometimes Lead to Unnecessary Tests

University of Florida Health Cancer Center A new University of Florida study finds that male patients who have a single general physician were more likely to receive a prostate cancer screening test during a period when the test was not recommended by the U.S. Preventive Services Task Force. Read More

Patients With Metastatic Breast Cancer and High Mutational Burden Benefit From Pembrolizumab

University of Michigan Rogel Cancer Center The immunotherapy agent pembrolizumab can provide clinical benefit to some patients with metastatic breast cancer whose tumors were found to have a high number of mutations, and whose cancer continued to progress with standard treatments. Read More

New CRISPR Technology Offers Unrivaled Control of Epigenetic Inheritance

UCSF Helen Diller Family Comprehensive Cancer Center In a new paper, researchers at UC San Francisco and the Whitehead Institute describe a CRISPR-based tool called "CRISPRoff," which allows scientists to switch off almost any gene in human cells without making a single edit to the genetic code. Read More

Drug Derived From Kentucky-Grown Plant Shows Promise for Ovarian Cancer Treatment

UK Markey Cancer Center A new study from UK Markey Cancer Center researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer. Read More
Zheng Named Associate Director for Population Sciences Research

Zheng Named Associate Director for Population Sciences Research

Vanderbilt-Ingram Cancer Center Wei Zheng, MD, PhD, MPH, has been named associate director for Population Sciences Research at Vanderbilt-Ingram Cancer Center. He replaces William Blot, PhD, who retired from the leadership position on April 1. Read More
Gordon Receives Kober Medal

Gordon Receives Kober Medal

Siteman Cancer Center Jeffrey I. Gordon, MD, has been awarded the George M. Kober Medal from the Association of American Physicians in recognition of his contributions to the field of gut microbiome research. Dr. Gordon, a research member of Siteman Cancer Center, is considered to be the father of the field. Read More

American Cures Act

This is a bill to prove 5% real funding increases to National Institutes of Health (NIH), Centers for Disease Control (CDC), Department of Defense (DoD) medical research, and Department of Veterans Affairs (VA) medical research for each of the next ten fiscal years.

New Initiative to Increase Patient Engagement

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center has begun utilizing a new program called MyCareCompass that is designed to support patients with necessary information about their care by sending that information directly to them. Read More

Protein Identified That Could Serve as Therapeutic Target in Lung Cancer

VCU Massey Comprehensive Cancer Center Scientists at VCU Massey Cancer Center have identified a protein that operates in tandem with a specific genetic mutation to spur lung cancer growth and could serve as a therapeutic target to treat the disease. Read More
New Chief of Hematology Oncology Named

New Chief of Hematology/Oncology Named

UPMC Hillman Cancer Center Taofeek K. Owonikoko, MD, PhD, will join the UPMC Hillman Cancer Center and Department of Medicine at the University of Pittsburgh as chief of the Division of Hematology/Oncology. He also will serve as associate director for translational research and co-leader of the Cancer Therapeutics Program at Hillman. Read More
Advances in Brain Cancer Research Lead to 3 Million Award

Advances in Brain Cancer Research Lead to $3 Million Award

Cancer Center at Illinois Several Cancer Center at Illinois members are joining forces with scientists from the Mayo Clinic and Georgetown University on an expansive project targeting improved treatment for glioblastoma. The team, led by Brendan Harley, PhD, recently received a $3 million grant from the National Cancer Institute for their research. Read More

$3 Million Grant Awarded to Apply AI to Lung Cancer Immunotherapy

Case Comprehensive Cancer Center Researchers from Case Western Reserve University, New York University, and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy. Read More
Lu Named EDT Co Program Leader

Lu Named EDT Co-Program Leader

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Xiongbin Lu, PhD, has been named co-program leader of the Experimental and Developmental Therapeutics (EDT) research program. He has made important discoveries promoting translational development of human cancer research, including breast cancer targeted therapy and immunotherapy. Read More

New Research Suggests Breast Cancer Treatment in Patients Over Age 70 Can Be Safely Reduced

UPMC Hillman Cancer Center A study by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine suggests the rate of cancer recurrence or survival may be no different in treated versus untreated elderly patients diagnosed in the early stages of breast cancer. Read More

Bone Microenvironment Fosters Breast Cancer Metastatic Behavior

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Two studies led by Baylor College of Medicine shed new light on the unanswered question of why estrogen receptor-positive (ER+) breast cancer sometimes grows back in the bone and spreads to other tissues despite effective endocrine therapies directed at ER. Read More
Mohan Joins Moffitt as New Vice President of Digital

Mohan Joins Moffitt as New Vice President of Digital

Moffitt Cancer Center Santosh Mohan, MMCi, CPHIMS, FHIMSS, has joined Moffitt Cancer Center as the new vice president of digital. This newly created position will be instrumental in Moffitt’s success as the cancer center accelerates its digital capabilities to advance cancer care, treatment, and research. Read More
Knudsen to Step Down as AACI President

Knudsen to Step Down as AACI President

AACI President Karen E. Knudsen, MBA, PhD, is resigning from Sidney Kimmel Cancer Center (SKCC) at Jefferson Health in Philadelphia. She will step down as AACI president and begin her new role as chief executive officer of the American Cancer Society (ACS) on Tuesday, June 1. Dr. Knudsen will be the first woman CEO to lead the 107-year-old organization and the American Cancer Society Cancer Advocacy Network (ACS CAN). Read More

Study Revises Understanding of Cancer Metabolism

Vanderbilt-Ingram Cancer Center Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. Read More
Sacks Named Division Director in Plastic and Reconstructive Surgery

Sacks Named Division Director in Plastic and Reconstructive Surgery

Siteman Cancer Center Justin M. Sacks, MD, has been named director of the Division of Plastic and Reconstructive Surgery at Washington University School of Medicine in St. Louis. Dr. Sacks will treat patients at Siteman Cancer Center. Read More

Physician-Researcher Tapped to Lead Cancer Genetics and Genomics Department

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center has appointed Agnes Witkiewicz, MD, as director of cancer genetics and genomics. She will also hold the John & Santa Palisano Endowed Chair of Cancer Genetics. Read More
Sharifi Honored With AACR Achievement Award

Sharifi Honored With AACR Achievement Award

Case Comprehensive Cancer Center The Case Comprehensive Cancer Center congratulates the Cleveland Clinic's Nima Sharifi, MD, on his selection as the 2021 recipient of the American Association for Cancer Research (AACR) Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. Read More

New CAR T Approach Minimizes Resistance, Helps Avoid Relapse in Non-Hodgkin's B-Cell Lymphoma

UCLA Jonsson Comprehensive Cancer Center Early results from a chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimize treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's B-cell lymphoma that has returned or not responded to treatment. Read More

Information Theory Recruited to Help Scientists Find Cancer Genes

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Using a field of mathematics designed mainly to study how digital and other forms of information are measured, stored, and shared, scientists at Johns Hopkins Medicine and Johns Hopkins Kimmel Cancer Center say they have uncovered a likely key genetic culprit in the development of acute lymphoblastic leukemia. Read More
Discovery Could Revive Failed Treatments for Solid Tumors

Discovery Could Revive Failed Treatments for Solid Tumors

University of Virginia Cancer Center New research from the UVA Cancer Center’s Jogender Tushir-Singh, PhD, could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon, and triple-negative breast cancer, that ultimately failed in human clinical trials. Read More
Faculty Leader Named for Cancer Therapy Discovery and Development

Faculty Leader Named for Cancer Therapy Discovery and Development

University of Wisconsin Carbone Cancer Center Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development program at the University of Wisconsin Carbone Cancer Center. Read More
Balderson Leads National Physician Assistants Organization

Balderson Leads National Physician Assistants Organization

Duke Cancer Institute, Duke University Medical Center Duke Cancer Institute physician assistant Scott Balderson, PA-C, has begun his term as president of the national Association of Physician Assistants in Cardiothoracic and Vascular Surgery. The association has more than 700 members and supports advocacy, medical education, and professional recertification. Read More
Holcombe Named Director of UVMCC

Holcombe Named Director of UVMCC

Randall F. Holcombe, MD, MBA, has been appointed director of The University of Vermont Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. He joins UVMCC from the National Cancer Institute (NCI)-Designated University of Hawai'i Cancer Center, where he has served as director since 2016. Dr. Holcombe will begin his tenure on August 1. He succeeds Richard Galbraith, MD, PhD, and Chris Holmes, MD, PhD, who became interim co-directors of UVMCC in…
Reps Higgins Bilirakis to Receive Cancer Research Ally Award

Reps. Higgins, Bilirakis to Receive Cancer Research Ally Award

Representatives Brian Higgins (D-NY) and Gus Bilirakis (R-FL) will be honored with the Cancer Research Ally Award at the 2021 AACI/AACR Hill Day, which will be held virtually on June 9. Both congressmen will deliver remarks as part of the event’s lunchtime programming. Read More

Project Explores Text Messages for Smoking Cessation

Wilmot Cancer Institute, UR Medicine A Wilmot Cancer Institute team is launching a two-year research project to develop different types of text messages for smoking cessation, and then study them in clinical trials to find out what works best. Read More

Liquid Biopsy Test Developed for Lymph Node Metastasis in Early-Stage T1 Colorectal Cancer

City of Hope Comprehensive Cancer Center Scientists at City of Hope have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma. Read More

Genetic Diversity Within Tumors Suggests Continuous Evolution

The University of Texas MD Anderson Cancer Center Analyzing tumors from more than 2,600 patients and 38 cancer types, researchers from The University of Texas MD Anderson Cancer Center and the international Pan-Cancer Analysis of Whole Genomes Consortium have characterized the extensive genetic diversity across cancer and within individual tumors. Read More
Senior Director of Clinical Research Innovation Appointed

Senior Director of Clinical Research Innovation Appointed

Huntsman Cancer Institute at the University of Utah Neeraj Agarwal, MD, a physician-scientist at Huntsman Cancer Institute, has been appointed senior director of clinical research innovation, overseeing critical components of Huntsman's clinical research infrastructure. Read More
Markham Appointed as Chief of Hematology and Oncology

Markham Appointed as Chief of Hematology and Oncology

University of Florida Health Cancer Center Merry Jennifer Markham, MD, FACP, FASCO, has been appointed as chief of the division of hematology and oncology in the UF College of Medicine. Dr. Markham has served as the associate director for medical affairs for the UF Health Cancer Center since 2017. Read More
Maihle Wins DOD Award

Maihle Wins DOD Award

UMMC Cancer Center and Research Institute A $2.7 million U.S. Department of Defense Ovarian Cancer Academy Leadership Award has been awarded to Nita Maihle, PhD. She shares the award with Douglas Levine, MD, a gynecologic oncologist at New York University. Read More
CRI Keynote Spotlight Mary Dicey Jackson Scroggins

CRI Keynote Spotlight: Mary 'Dicey' Jackson Scroggins

Mary "Dicey" Jackson Scroggins, MA, will deliver the keynote presentation on Wednesday, July 14 during the 13th Annual AACI CRI Meeting. Scroggins, a 24-year ovarian cancer survivor and recent acute myeloid leukemia (AML) survivor, research advocate, and health activist, is driven by a commitment to global health equity. Read More

Study Seeks to Understand Effectiveness of COVID-19 Vaccination in Cancer Patients, Survivors

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A study at OSUCCC - James will evaluate how COVID-19 impacts the immune system of cancer patients. The study will look at whether the COVID-19 vaccine is less effective in cancer patients receiving certain therapies, and how long immunity lasts. Read More

New Method Developed for Identifying Mutational Signatures in Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Researchers at the Johns Hopkins Kimmel Cancer Center used machine learning techniques to detect mutational signatures in cancer patients. Their algorithm outperformed the current standard of analysis and revealed new mutational signatures associated with obesity. Read More

Black Prostate Cancer Patients Face Higher Risk of Cardiovascular Disease-Related Mortality Than White Patients

Sidney Kimmel Cancer Center at Jefferson Health Cardiovascular disease-related mortality among prostate cancer patients is significantly higher among Black patients compared with white patients, according to research from the Sidney Kimmel Cancer Center at Jefferson Health. Read More

Roswell Park, Wilmot Partner on First Large Study of Immunotherapy in Black Cancer Patients

Roswell Park Comprehensive Cancer Center Funded by a two-year, $2.08 million grant from the National Cancer Institute, a new collaboration between two western New York cancer research leaders will help oncologists learn whether Black and white cancer patients respond differently to a game-changing immunotherapy treatment. Read More

End-of-Life Care Remains Aggressive for People With Ovarian Cancer

University of Michigan Rogel Cancer Center People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study. Read More
White Elected as a Fellow to the AACR Academy

White Elected as a Fellow to the AACR Academy

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey deputy director, Eileen White, PhD, has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy. Read More
Chi Receives Kastan Award

Chi Receives Kastan Award

Duke Cancer Institute, Duke University Medical Center The American Association for Cancer Research has named Jen-Tsan Ashley Chi, MD, PhD, as co-winner of the Molecular Cancer Research Michael B. Kastan Award for Research Excellence on behalf of his all-Duke research team for their paper, "A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer." Read More

Stem Cell Transplants Prevent Relapses of Most Common Childhood Cancer

University of Virginia Cancer Center Children and young adults who receive CAR T-cell therapy for acute lymphoblastic leukemia suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds. Read More

Pancreatic Cancer Cells Hijack Muscle Protein to Beef Up Their Metabolism

UCSF Helen Diller Family Comprehensive Cancer Center Cancer starts with mutations in a cell’s DNA, but new UC San Francisco research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows. Read More

Investigators Identify STING Gene Methylation Allows Melanoma to Evade the Immune System

Moffitt Cancer Center In a new article, Moffitt Cancer Center researchers demonstrate how an important defect in STING gene expression in melanoma cells contributes to their evasion from immune cell detection and destruction. Read More

Study Suggests Common Drug Could Be Used to Prevent Certain Skin Cancers

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute New data published by researchers at OSUCCC – James suggests that an oral drug currently used to treat neuromuscular diseases could also help prevent squamous cell skin cancer. Read More

Study Reveals a Unique Mode of Cell Migration on Soft Viscoelastic Surfaces

Stanford Cancer Institute To advance studies of cell migration, Stanford researchers have worked to develop and test new types of material that closely imitate the real tissue that surrounds cells. Read More

New Strategy Found for Fighting Brain Cancer

VCU Massey Comprehensive Cancer Center VCU Massey Cancer Center researcher Suyun Huang, PhD, recently discovered how cholesterol becomes dysregulated in brain cancer cells and showed that the gene responsible for it could be a target for future drugs. Read More

Genomic Data Commons Provides Unprecedented Cancer Data Resource

The University of Chicago Medicine Comprehensive Cancer Center The National Cancer Institute’s Genomic Data Commons, launched in 2016 by then-Vice President Joseph Biden and hosted at the University of Chicago, has become one of the largest cancer genomics resources, with more than 3.3 petabytes of data from more than 65 projects and over 84,000 anonymized patient cases. Read More

UAMS Surpasses 100,000 Digital Health Visits in Pandemic

UAMS Winthrop P. Rockefeller Cancer Institute The University of Arkansas for Medical Sciences conducted more than 100,000 digital health visits following the COVID-19 outbreak, seeing its highest numbers of virtual consultations at the height of the pandemic and during a February winter storm, performing more than 4,500 digital health visits per week. Read More

Call for Nominations: AACI Cancer Health Equity Award

Nominations are now being accepted for the 2021 AACI Cancer Health Equity Award. The award was created to recognize an individual or group who demonstrates exceptional leadership in promoting health equity, mitigating cancer disparities, and advocating for diversity and inclusion at their cancer center. The nomination period will close on Friday, May 28. Read More
Reminder Promote Your Cancer Center With a CRI Meeting Program Ad

Reminder: Promote Your Cancer Center With a CRI Meeting Program Ad

AACI invites you to promote your cancer center by purchasing an ad in the 13th Annual AACI CRI Meeting program. The digital program book offers an excellent opportunity to showcase your center while supporting the CRI meeting. Your cancer center’s program ad may highlight a conference or a new initiative, or celebrate the success of the center’s clinical trials office. Cancer centers may also include links to their website and any upcoming events. Read More
Seed Grant Leads to 1 25 Million NIH Grant for Breast Cancer Research

Seed Grant Leads to $1.25 Million NIH Grant for Breast Cancer Research

Cancer Center at Illinois In 2019, Cancer Center at Illinois (CCIL) member Prasanth Kumar V. Kannanganattu, PhD, received a $250,000 CCIL Seed Grant to support his research on the characterization of oncogenic noncoding RNAs in breast cancer progression and metastasis. The project has now been further funded by a $1.25 million National Institutes of Health (NIH) Research Grant. Read More

Award to Jump-Start Young Scientists Seeking to Cure Cancer

Cedars-Sinai Cancer Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, and Peter Kuhn, PhD, director of the Convergent Science Institute in Cancer at the USC Michelson Center for Convergent Bioscience, have received the inaugural Virtual Cancer Center Director Award to establish the Convergent Science Virtual Cancer Center. The center will guide emerging scholars from diverse science backgrounds and institutions to accelerate their research and careers. Read More
Increased Risk of Mortality Found for Arizona Hispanic Native American Kidney Cancer Patients

Increased Risk of Mortality Found for Arizona Hispanic, Native American Kidney Cancer Patients

The University of Arizona Cancer Center Ken Batai, PhD, a health disparities researcher at the UArizona Cancer Center, has documented an increased risk of mortality among Arizona’s Hispanic American and Native American kidney cancer patients compared with national data. Read More

$17.5 Million in CPRIT Grants Awarded for Cancer Research

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Baylor College of Medicine has been awarded more than $17.5 million in grants by the Cancer Prevention & Research Institute of Texas (CPRIT) to support cancer research and training. CPRIT awarded 25 new grants to institutions across Texas, totaling more than $69 million, including six grants to Baylor. Read More
Distinguished Scientist Mentor and Uro Oncology Research Pioneer Dies at 80

Distinguished Scientist, Mentor and Uro-Oncology Research Pioneer Dies at 80

Cedars-Sinai Cancer Leland W. Chung, PhD, who served as director of the Urologic Oncology Research Program at Cedars-Sinai Cancer for 12 years, died May 10 of kidney cancer. He was 80. Read More

$9 Million Contract Awarded for New Jersey State Cancer Registry

Rutgers Cancer Institute of New Jersey The New Jersey State Cancer Registry, under the direction of the State Department of Health in partnership with Rutgers Cancer Institute of New Jersey, has been awarded a seven-year, $9,085,109 contract from the National Cancer Institute to support core infrastructure and research activities as part of the Surveillance, Epidemiology, and End Results Program. Read More

Internship Program Aims to Boost Diversity in Cancer Care Workforce

Wilmot Cancer Institute, UR Medicine The University of Rochester has been selected by the American Society of Clinical Oncology as one of five host schools to participate in the inaugural Oncology Summer Internship (OSI) program for medical students from populations underrepresented in medicine. Read More
New Insights Into Androgens Action Could Boost Battle Against Prostate Cancer

New Insights Into Androgens' Action Could Boost Battle Against Prostate Cancer

University of Virginia Cancer Center Researchers at UVA Cancer Center have unveiled new insights into how androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian, and breast cancers. In a new paper, Bryce M. Paschal, PhD, and colleagues describe how a complex signaling system regulates androgen receptor activity. Read More

New AI-Based Tool Can Find Rare Cell Populations in Large Single-Cell Datasets

The University of Texas MD Anderson Cancer Center Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind artificial intelligence (AI)-based tool that can accurately identify rare groups of biologically important cells from single-cell datasets, which often contain gene or protein expression data from thousands of cells. Read More

CPRIT Renews Funding for Training Program Focused on Education and Research

The University of Texas MD Anderson Cancer Center The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded The University of Texas MD Anderson Cancer Center $4 million in continued funding for the MD Anderson Cancer Center CPRIT Research Training Program, which provides fundamental, interdisciplinary, and innovative training in cancer research for basic and translational scientists. Read More

Breast Microbiome-Immune Interactions May Influence Breast Cancer

Cleveland Clinic Cancer Center A recent study by Cleveland Clinic researchers suggests that interactions between the breast microbiome and local immune responses may influence breast cancer development and progression. The findings lay the foundation for future investigation into the factors associated with breast cancer initiation and will facilitate improved detection and prevention. Read More
Study to Examine Exosomes in Ovarian Cancer

Study to Examine Exosomes in Ovarian Cancer

The University of Kansas Cancer Center A research team co-led by Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center, and Yong Zeng, PhD, has been awarded a $3.1 million grant from the National Institutes of Health to investigate better ways to identify ovarian cancer earlier. Read More
DCI Nurse Receives National Recognition

DCI Nurse Receives National Recognition

Duke Cancer Institute, Duke University Medical Center Jessica Jin, RN, BSN, BMTCN, a clinical nurse III, is the 2021 Blood and Marrow Transplant Certified Nurse of the Year. The annual award by the Oncology Nursing Society recognizes a nurse who has made significant contributions to blood and marrow transplant nursing. Read More

Stony Brook Receives Funding Boost to Fight Cancer

Stony Brook Cancer Center The Stony Brook University Cancer Center has received funding from the New York State budget to help it attain National Cancer Institute (NCI)-Designated Cancer Center status. In the past four budgets the center has secured more than $2.6 million for major research activities, especially the development of cutting-edge clinical trials. Read More
Foundation Gives 1 8 Million to Myeloma Center

Foundation Gives $1.8 Million to Myeloma Center

UAMS Winthrop P. Rockefeller Cancer Institute The Paula and Rodger Riney Foundation has given $1.8 million to the University of Arkansas for Medical Sciences (UAMS) Myeloma Center in the Winthrop P. Rockefeller Cancer Institute. Rodger Riney is the founder of the discount brokerage firm Scottrade. He was diagnosed with multiple myeloma in 2015. Read More
Sugary Drinks Linked to Increased Risk of Colorectal Cancer in Women Under 50

Sugary Drinks Linked to Increased Risk of Colorectal Cancer in Women Under 50

Siteman Cancer Center Heavy consumption of sugary drinks during adolescence and adulthood might increase the risk of developing colorectal cancer in women under age 50, according to a new study by Washington University researchers at Siteman Cancer Center. Yin Cao, ScD, is senior author on the study. Read More
1 6 Million Awarded for IBC Research Project

$1.6 Million Awarded for IBC Research Project

Duke Cancer Institute, Duke University Medical Center A large group of Duke Cancer Institute investigators led by researcher Gayathri Devi, PhD, has been awarded a three-year $1.6 million U.S. Department of Defense Breakthrough Level 2 grant for research directed at investigating the mechanisms underlying inflammatory breast cancer metastasis. Read More

Studies Connect Mammary Hormone to Breast Cancer Progression, Uncover Potential for Novel Targeted Therapies

VCU Massey Comprehensive Cancer Center Two recent studies conducted at VCU Massey Cancer Center find strong evidence that prolactin acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple forms of the disease. Read More

Frailty in Cancer Patients, Young and Old, is Linked to Inflammation

Wilmot Cancer Institute, UR Medicine For women with breast cancer, frailty is linked to inflammation levels in the blood, according to a Wilmot Cancer Institute investigation. Higher inflammation prior to chemotherapy can predict frailty after chemotherapy ends. Read More
Seeking to Expand Targeted Therapy for Lung Cancer

Seeking to Expand Targeted Therapy for Lung Cancer

Fred Hutchinson Cancer Center After reduced smoking rates, drugs that target signature alterations in tumor cells are the main reason that the death rate has dropped for people diagnosed with lung cancer. Recently, Alice Berger, PhD, received a National Institutes of Health MERIT Award that will support her efforts to extend these advances. Read More
Chief Pharmacy Officer Earns Career Honor From Professional Society

Chief Pharmacy Officer Earns Career Honor From Professional Society

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center congratulates its chief pharmacy officer, Lijian “Leo” Cai, PharmD, who will receive the 2021 Donald E. Francke Medal from the American Society of Health System Pharmacists in recognition of his long record of significant professional achievements. Read More

Targeting Abnormal Cell Metabolism Shows Promise Against Pediatric Brain Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer. Read More

Study Suggests Path to Blocking Common Genetic Driver of Lung Cancer

University of Michigan Rogel Cancer Center While new inhibitors are demonstrating some success against a type of KRAS, new paths are needed. A study from the University of Michigan Rogel Cancer Center found that a protein called AGO2 could be a key to slowing tumor growth in non-small cell lung cancer. Read More

Research Team Takes Gene Mutation Detection in Blood to the Next Level

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Johns Hopkins Kimmel Cancer Center researchers have developed a new technology to overcome the inefficiencies and high error rates common among next-generation sequencing techniques that have previously limited their clinical application. Read More

Personalized Cancer Vaccine Shows Potential Benefit Against Multiple Tumor Types

The Tisch Cancer Institute at Mount Sinai A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence. Read More
Site Director For Radiology Appointed

Site Director For Radiology Appointed

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center announces the appointment of Jordan Anaokar, MD, as the new site director for radiology. She specializes in over a dozen different kinds of cancer with a treatment focus on gastrointestinal, genitourinary, and thoracic imaging, and has been director of the Fox Chase Diagnostic Imaging Protocol Lab since 2020.  Read More
Mc Elfish Named Associate Director of Community Outreach and Engagement

McElfish Named Associate Director of Community Outreach and Engagement

UAMS Winthrop P. Rockefeller Cancer Institute Pearl McElfish, PhD, MBA, has been named associate director of community outreach and engagement at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. Read More

Researchers Develop Direct-Acting Antiviral to Treat COVID-19

City of Hope Comprehensive Cancer Center An international team of scientists from City of Hope and the Menzies Health Institute Queensland at Griffith University have developed an experimental direct-acting antiviral therapy to treat COVID-19. Read More

Changes in Approach to Cervical Cancer Examined Following Publication of Trial Results

Case Comprehensive Cancer Center In a new article, researchers from University Hospitals Cleveland Medical Center and New York Presbyterian Hospital – Weill Cornell Medicine in New York found a substantial reduction in the use of minimally invasive surgery for cervical cancer after publication of the results of a major study, called the Laparoscopic Approach to Cervical Cancer, in 2018. Read More
Rutgers Leader Elected as a Member to the National Academy of Sciences

Rutgers Leader Elected as a Member to the National Academy of Sciences

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey Deputy Director Eileen White, PhD, has been elected to the National Academy of Sciences. She is among 120 members elected this year in recognition of their distinguished and continuing achievements in original research. Read More
Lerman Takes the Reins as AACI President

Lerman Takes the Reins as AACI President

Caryn Lerman, PhD, is the new president of AACI. Dr. Lerman is the director of University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles and the associate dean for cancer programs and the H. Leslie and Elaine S. Hoffman Professor in Cancer Research at Keck School of Medicine of USC. Dr. Lerman will begin her two-year term four months early due to Karen E. Knudsen, MBA, PhD, stepping down to become the new chief executive officer of the American Cancer Society. R…

Triple-Negative Breast Cancer More Deadly for African American Women

Siteman Cancer Center Non-Hispanic African American women with triple-negative breast cancer do not fare as well as non-Hispanic white women with this type of breast cancer, according to new research from Washington University researchers at Siteman Cancer Center. The study demonstrates the need for additional research to address disparities in cancer care. Read More

A Calculator That Predicts Risk of Lung Cancer Underperforms in Diverse Populations

Sidney Kimmel Cancer Center at Jefferson Health Researchers at Jefferson have found that a commonly used risk prediction model does not accurately identify high-risk Black patients who could gain life-saving benefit from early screening. Read More
Rodriguez is First Chief Diversity and Equity Officer for Faculty

Rodriguez is First Chief Diversity and Equity Officer for Faculty

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center announces the promotion of Elisa M. Rodriguez, PhD, MS, to chief diversity and equity officer for faculty. The new role provides expanded opportunities for Dr. Rodriguez to apply her deep-rooted commitment to improving the lives of people from underserved communities. Read More

Researchers Discover First Immune Stimulating Long Noncoding RNA Involved in Body's Response to Cancer

University of Michigan Rogel Cancer Center A long noncoding RNA whose function was previously unknown turns out to play an important role in promoting the body’s immune response against cancer and holds promise for enhancing the efficacy of anti-cancer immunotherapy. Read More
Researchers Discover an Entirely New Kind of Biomolecule

Researchers Discover an Entirely New Kind of Biomolecule

Stanford Cancer Institute Stanford researchers have discovered a new kind of biomolecule that could play a significant role in the biology of all living things. The novel biomolecule, dubbed glycoRNA, is a small ribbon of ribonucleic acid (RNA) with sugar molecules, called glycans, dangling from it. Carolyn Bertozzi, PhD, is the study's senior author. Read More

Bisphosphonates in Breast Cancer

Fred Hutchinson Cancer Center Breast cancer patients, particularly those with metastatic disease, take bisphosphonates to prevent and treat bone lesions. A new analysis by scientists at Fred Hutchinson Cancer Research Center suggests the drugs might keep people diagnosed with the very earliest form of breast cancer from developing invasive disease. Read More

Team Science Award Recognizes Pediatric Cancer Researchers

Stanford Cancer Institute Eight Stanford Medicine scientists are among a group of pediatric cancer researchers being honored with the 2021 Team Science Award from the American Association for Cancer Research. Read More